Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedA sitewide NIH notice announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides a link to updates and FAQs.SummaryDifference0.3%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check35 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the previous revision v3.6.6. This reflects an updated version of the record in the history log.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history and the prior revision v3.6.5 was removed, updating the record timeline. This update relates to historical record maintenance rather than substantive changes to the trial content.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded a new revision marker 'Revision: v3.6.5' to the study record history. The older 'Revision: v3.6.4' entry and the 'References' section were removed.SummaryDifference0.1%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.